Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders and psychiatric conditions. Its structure supports the construction of complex piperazine-based molecules with potential antipsychotic or antidepressant activity. The tert-butyloxycarbonyl (Boc) protecting group allows for controlled reactivity during multi-step synthesis, making it valuable in medicinal chemistry for selective amine functionalization. Commonly employed in research settings for optimizing drug candidates requiring fluorinated aromatic moieties linked to piperazine scaffolds.